Mbx Biosciences, Inc. · NASDAQ:MBX
Norwest Venture Partners XVI, LP reported a 4.80% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Sep 26, 2025 · Filed Sep 30, 2025
Norwest Venture Partners XVI, LP reported a 4.80% stake in Mbx Biosciences, Inc., 2,136,335 shares, with active intent on Sep 26, 2025. Filed Sep 30, 2025 (Schedule 13D/A).
- Stake
- 4.80%
- Shares
- 2,136,335
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Norwest Venture Partners XVI, LP | 4.80% | 2,136,335 |
| Genesis VC Partners XVI, LLC | 4.80% | 2,136,335 |
| NVP Associates, LLC | 4.80% | 2,136,335 |
| Jeffrey Crowe | 4.80% | 2,136,335 |
| Jon Erik Kossow | 4.80% | 2,136,335 |
| Tiba Aynechi | 4.80% | 2,140,989 |
Source
Related
- Mbx Biosciences, Inc.
- Norwest Venture Partners XVI, LP
- Mbx Biosciences, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026